Skip to main content
. 2019 Jul 23;10(45):4664–4678. doi: 10.18632/oncotarget.27083

Figure 1. MiR-190b expression and methylation status in breast derived cell lines.

Figure 1

(A, left panel) MiR-190b expression is higher in ER+ breast cancer cell lines (n = 7) compared to ER– breast cancer cell lines (n = 9) (Wilcoxon rank sum test P = 0.011). Right panel- MiR-190b expression in breast cancer cell lines. (B, left panel) MiR-190b methylation is lower in ER+ (n = 7) compared to ER– cell lines (n = 9) (Wilcoxon rank sum test, P = 0.003). (Right panel) MiR-190b methylation in breast cancer cell lines.